Gray's Pharma Private Limited

Gray's Pharma Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
CIN U74900PN2015PTC155546 Incorporated 24 June 2015 ROC Pune HQ Pune, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.53 Cr
▲ 37% YoY
Net profit · FY 2025
₹15.83 Lakh
Net margin 10.3%
EBITDA · FY 2025
₹15.83 Lakh
EBITDA margin 10.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Gray's Pharma Private Limited

Data last updated:

Gray's Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 June 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74900PN2015PTC155546. Its GSTIN is 27AAGCG0238B1Z4 (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kanchan Singh and Ravendra Banaphar Singh.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Unit No. 425 Sr. No.17/1A/1(P), Goodwill Squarepune City Pune (Cb), Maharashtra, India – 411015.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.53 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹15.83 Lakh (net margin 10.3%) and EBITDA of ₹15.83 Lakh (EBITDA margin 10.3%). Revenue has grown at a compounded annual rate (CAGR) of 49% over three years and 23% over five years.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website grayspharma.in.

Company Details of Gray's Pharma Private Limited
CIN U74900PN2015PTC155546
Registration Number 155546
Incorporation Date 24 June 2015
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Unit No. 425 Sr. No.17/1A/1(P), Goodwill Squarepune City Pune (Cb), Maharashtra, India – 411015
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Gray's Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Gray's Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Gray's Pharma Private Limited in one report.

Financials from FY 2016 Directors & ownership Charges & compliance

Business Activity of Gray's Pharma Private Limited

The main business activity of Gray's Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparationsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Gray's Pharma Private Limited FY 2024 filings available

Gray's Pharma Private Limited reported revenue of ₹1.53 Cr (up 37% YoY) for FY 2025.

Revenue · FY 2025
₹1.53 Cr ▲ 37%
Net profit · FY 2025
₹15.83 Lakh margin 10.3%
EBITDA · FY 2025
₹15.83 Lakh margin 10.3%

Compounded Annual Growth Rate (CAGR) of Gray's Pharma Private Limited

Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 49%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 81%
5 years · compounded
▲ 50%

Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 37% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Gray's Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹15.83 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹15.83 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Gray's Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin10.3%••••••••••••••••
Net Profit Margin10.3%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gray's Pharma are in the company report.

Premium access

Financial statements from FY 2016

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Gray's Pharma Private Limited

Gray's Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kanchan SinghDirector11 Aug 20233 Years 2 MonthsCurrent
Ravendra Banaphar SinghDirector24 Jun 201511 Years 3 MonthsCurrent

Peer Comparison of Gray's Pharma Private Limited

Gray's Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
A Klass Drugs and Pharmaceuticals Private Limited₹1.54 Cr (FY 2024)••••••••-32.0%••••Khamgaon, Maharashtra, India
Kunnj Healthcare Private Limited₹1.54 Cr (FY 2025)••••••••34.0%••••Kalol, Gujarat, India
Vetrx Formulations Private Limited₹1.54 Cr (FY 2025)••••••••-12.0%••••Kanpur, Uttar Pradesh, India
Nexzen Formulations Limited₹1.54 Cr (FY 2025)••••••••-11.0%••••Chennai, Tamil Nadu, India
Styla Pharmaceutical Private Limited₹1.54 Cr (FY 2024)••••••••40.0%••••Chandigarh, India
Gray's Pharma Private Limited this company₹1.53 Cr (FY 2025)••••••••37.0%••••Pune, Maharashtra, India
Emergee Pharma Private Limited₹1.53 Cr (FY 2025)••••••••10.0%••••Uttar Pradesh, India
Leelabco Remedies Private Limited₹1.53 Cr (FY 2025)••••••••••••Noida, Uttar Pradesh, India
Lalith Pharma-Marketing Private Limited₹1.53 Cr (FY 2025)••••••••20.0%••••Banagalore, Karnataka, India
Shree Vishwamitra Ayurved Pharmaceuticals Private Limited₹1.53 Cr (FY 2025)••••••••10.0%••••Ahmedabad, Gujarat, India
Afd Laboratories Private Limited₹1.53 Cr (FY 2023)••••••••3.0%••••Mumbai, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Gray's Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Gray's Pharma Private Limited

Gray's Pharma Private Limited is audited by Aashish Londhe & Associates for the financial year 2023.

NameStatusAppointment DateCessation Date
Aashish Londhe & AssociatesLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Gray's Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Gray's Pharma Private Limited

Gray's Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Gray's Pharma Private Limited

Employment history and EPFO contributions of people linked to Gray's Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Gray's Pharma Private Limited

Gray's Pharma Private Limited has 6 board changes on record since 2015: 2 appointments and 4 cessations. The latest: Kanchan Singh ceased to be Additional Director on 29 Sep 2023.

AGM
Gray'S Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Gray'S Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
Ceased
Kanchan Singh ceased to be Additional Director.
Appointed
Kanchan Singh was appointed as Director.
Ceased
Vaishali Sunilsingh Rajput ceased to be Additional Director.
Ceased
Suhas Dhansingh Rajput ceased to be Director.
Ceased
Akshay Nandkishor Joshi ceased to be Director.
Appointed
Ravendra Banaphar Singh was appointed as Director.
Incorporation
24 Jun 2015
Gray'S Pharma Private Limited was registered on 24 Jun 2015 with Roc Pune & aged 11 years 3 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Gray's Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Gray's Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Gray's Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Gray's Pharma Private Limited

Gray's Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAGCG0238B1Z4MaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Gray's Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gray's Pharma Private Limited

Gray's Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 June 2015 (11+ years old) and is registered under CIN U74900PN2015PTC155546.

Gray's Pharma reported revenue of ₹1.53 Cr for FY 2025 (up 37% YoY).

Gray's Pharma has 2 current directors:

Gray's Pharma reported a net profit of ₹15.83 Lakh (net margin 10.3%) and EBITDA of ₹15.83 Lakh (EBITDA margin 10.3%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Gray's Pharma is 49% over three years and 23% over five years. In the latest year (FY 2025) revenue rose 37%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Gray's Pharma is 27AAGCG0238B1Z4, registered in Maharashtra.

The CIN (Corporate Identification Number) of Gray's Pharma is U74900PN2015PTC155546. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Gray's Pharma was incorporated on 24 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Pune.

The peers of Gray's Pharma by revenue are A Klass Drugs and Pharmaceuticals Private Limited, Kunnj Healthcare Private Limited, Vetrx Formulations Private Limited, Nexzen Formulations Limited, Styla Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Formulations).

Kanchan Singh ceased to be Additional Director on 29 Sep 2023. Kanchan Singh was appointed as Director on 11 Aug 2023. Vaishali Sunilsingh Rajput ceased to be Additional Director on 30 Sep 2017. Gray's Pharma has 6 board changes on record in total.

Gray's Pharma can be reached through the website grayspharma.in. Its registered office is in Pune, Maharashtra, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available